Nicotine 2 mg Oral Lozenge
RxNorm 359817
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 359817 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: nicotine 2 mg Oral Lozenge.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Nicotine 2 mg Oral Lozenge
(Atom ID: 12348042)
PTPrescribable
Designated preferred name (PT):
Nicotine (as nicotine polacrilex) 2 mg oromucosal lozenge
(Atom ID: 11437759)
SYPrescribable
Synonym (SY):
Nicotine 2 mg (as nicotine polacrilex 11.1 mg) Oral Lozenge
(Atom ID: 6830257)
PSNPrescribable
Prescribable Name (PSN):
Nicotine 2 mg Oral Lozenge
(Atom ID: 6370528)
SYPrescribable
Synonym (SY):
Nicotine 2 mg Troche
(Atom ID: 3054305)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely nicotine (as nicotine polacrilex) 2 mg/1 each conventional release oromucosal lozenge (clinical drug)
(Atom ID: 11440388)
Patient Education
Nicotine Lozenges
Nicotine lozenges are used to help people stop smoking. Nicotine lozenges are in a class of medications called smoking cessation aids. They work by providing nicotine to your body to decrease the withdrawal symptoms experienced when smoking is stopped and to reduce the urge to smoke.
[Learn More]
* Please review the disclaimer below.